Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Jayne

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Trials|March 11, 2023
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocolMark E McClure, Seerapani Gopaluni, James Wason, et al.
Nature Immunology|January 31, 2025
Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challengeMatthew L Coates, Nathan Richoz, Zewen K Tuong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2023
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II TrialDavid R Jayne, Jürgen Steffgen, Juanita Romero-Diaz, et al.
The Journal of Rheumatology|December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7Peter A Merkel, Philip Seo, Peter Aries, et al.
Rheumatology (Oxford, England)|December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseasesSonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
RMD Open|September 29, 2017
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content expertsMax Yates, Richard Watts, Ingeborg Bajema, et al.
European Heart Journal Open|October 18, 2021
Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosisChristopher Wall, Yuan Huang, Elizabeth P V Le, et al.
Journal of the American College of Cardiology|January 25, 2023
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and AtherosclerosisAndrej Ćorović, Christopher Wall, Meritxell Nus, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Trials|March 11, 2023
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocolMark E McClure, Seerapani Gopaluni, James Wason, et al.
Nature Immunology|January 31, 2025
Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challengeMatthew L Coates, Nathan Richoz, Zewen K Tuong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2023
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II TrialDavid R Jayne, Jürgen Steffgen, Juanita Romero-Diaz, et al.
The Journal of Rheumatology|December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7Peter A Merkel, Philip Seo, Peter Aries, et al.
Rheumatology (Oxford, England)|December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseasesSonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
RMD Open|September 29, 2017
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content expertsMax Yates, Richard Watts, Ingeborg Bajema, et al.
European Heart Journal Open|October 18, 2021
Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosisChristopher Wall, Yuan Huang, Elizabeth P V Le, et al.
Journal of the American College of Cardiology|January 25, 2023
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and AtherosclerosisAndrej Ćorović, Christopher Wall, Meritxell Nus, et al.
Pageof 3